1 | 18F-FDG | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | 1件: Fludeoxyglucose F 18
Fludeoxyglucose F 18
💬
| - | - | 8件: 5 5, 6, 7, 46, 84, 85, 127, 300 💬
|
2 | 20MM sodium pyruvate nasal spray | - | - | - | - | 1件: 85 85 💬
|
3 | 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt | - | - | - | - | 2件: 51 51, 85 💬
|
4 | 534-1508 | - | - | - | - | 1件: 85 85 💬
|
5 | 60% oxygen | - | - | - | - | 1件: 85 85 💬
|
6 | 68GA-BMV101 | - | - | - | - | 1件: 85 85 💬
|
7 | 9mw3811 injection | - | - | - | - | 1件: 85 85 💬
|
8 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 10件: 34 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
|
9 | ACT-064992 | - | - | - | - | 5件: 51 51, 85, 86, 88, 210 💬
|
10 | Activated charcoal | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 2件: 13 13, 85 💬
|
11 | Adult human mesenchymal stem cells | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 2件: 85 85, 96 💬
|
12 | Aerosol interferon-gamma | - | - | - | - | 1件: 85 85 💬
|
13 | AGMB-447 | - | - | - | - | 1件: 85 85 💬
|
14 | AIR | - | - | - | - | 2件: 85 85, 97 💬
|
15 | Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 18件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
|
16 | Allorx | - | - | - | - | 8件: 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
17 | AMB-05X | - | - | - | - | 1件: 85 85 💬
|
18 | Ambrisentan | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 51 51, 66, 84, 85, 86, 88, 210, 211 💬
|
19 | ANG-3070 | - | - | - | - | 1件: 85 85 💬
|
20 | Anlotinib | 1件: Anlotinib Anlotinib | 1件: Catequentinib
Catequentinib
💬
| 10件: FGFR1 FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬
| 36件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
21 | Anticorpo monoclonale antagonista DEL fattore xiia | - | - | - | - | 1件: 85 85 💬
|
22 | Antimicrobial therapy: CO-trimoxazole or doxycycline | - | - | - | - | 1件: 85 85 💬
|
23 | AP01 | - | - | - | - | 1件: 85 85 💬
|
24 | ARO-MMP7 inhalation solution | - | - | - | - | 1件: 85 85 💬
|
25 | ART-123 | - | - | - | - | 1件: 85 85 💬
|
26 | Artesunate oral product | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 2件: 18 18, 85 💬
|
27 | Atezolizumab | 1件: Atezolizumab Atezolizumab | 1件: Atezolizumab
Atezolizumab
💬
| 1件: PDL1 PDL1 💬
| 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 💬
|
28 | AUTO-titrating oxygen system | - | - | - | - | 1件: 85 85 💬
|
29 | Autoantibody reductive therapy | - | - | - | - | 1件: 85 85 💬
|
30 | Autologous mesenchymal stem cells derived from bone marrow | - | - | - | - | 1件: 85 85 💬
|
31 | Axatilimab | 1件: Axatilimab Axatilimab | 1件: Axatilimab
Axatilimab
💬
| 1件: CSF1R CSF1R 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, MAPK signaling pathway, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 85 85 💬
|
32 | Azapred | - | - | - | - | 1件: 85 85 💬
|
33 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
34 | Azathioprine/prednisone | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 85 85 💬
|
35 | AZD5055 | - | - | - | - | 1件: 85 85 💬
|
36 | Azithromycin | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 💬
|
37 | Bardoxolone methyl | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | 5件: 67 67, 84, 85, 86, 218 💬
|
38 | BBT-877 | 1件: BBT-877 BBT-877 | - | - | - | 1件: 85 85 💬
|
39 | BBT-877, multiple doses | 1件: BBT-877 BBT-877 | - | - | - | 1件: 85 85 💬
|
40 | BBT-877, single dose | 1件: BBT-877 BBT-877 | - | - | - | 1件: 85 85 💬
|
41 | Beclometasone dipropionate | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 3件: Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 85 85, 97 💬
|
42 | Belumosudil | 1件: Belumosudil Belumosudil | 2件: Belumosudil
Belumosudil
,
Belumosudil mesylate
💬
| 1件: ROCK2 ROCK2 💬
| 22件: Adherens junction Adherens junction, Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 85, 228 💬
|
43 | Bevacizumab | 1件: Bevacizumab Bevacizumab | 1件: Bevacizumab
Bevacizumab
💬
| 1件: VEGFA VEGFA 💬
| 23件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 8件: 13 13, 34, 85, 87, 89, 227, 280, 331 💬
|
44 | BG00011 | - | - | - | - | 1件: 85 85 💬
|
45 | BI 1015550 | - | - | - | - | 2件: 51 51, 85 💬
|
46 | BI 1015550 18 MG film coated tablet | - | - | - | - | 1件: 85 85 💬
|
47 | BI 1015550 9 MG film coated tablet | - | - | - | - | 1件: 85 85 💬
|
48 | BI 1819479 | - | - | - | - | 1件: 85 85 💬
|
49 | BI 1839100 | - | - | - | - | 1件: 85 85 💬
|
50 | Bibf 1120 | - | - | - | - | 2件: 51 51, 85 💬
|
51 | Bibf 1120 ES | - | - | - | - | 1件: 85 85 💬
|
52 | BIBF1120 | - | - | - | - | 1件: 85 85 💬
|
53 | BLD-0409 | 1件: Cudetaxestat Cudetaxestat | - | - | - | 1件: 85 85 💬
|
54 | BLD-2660 | - | - | - | - | 1件: 85 85 💬
|
55 | Blood sample collection | - | - | - | - | 1件: 85 85 💬
|
56 | BMS-986020 | 1件: BMS-986020 BMS-986020 | - | - | - | 2件: 51 51, 85 💬
|
57 | BMS-986278 | 1件: BMS-986278 BMS-986278 | - | - | - | 1件: 85 85 💬
|
58 | Bone marrow mesenchymal stem cells | - | - | - | - | 1件: 85 85 💬
|
59 | Bosentan | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,
Bosentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
60 | Broncho-vaxom | 1件: OM85 OM85 | - | - | - | 1件: 85 85 💬
|
61 | BSC | - | - | - | - | 1件: 85 85 💬
|
62 | Buloxibutid | 1件: Buloxibutid Buloxibutid | 2件: Buloxibutid
Buloxibutid
,
Buloxibutid sodium
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
63 | C106 solution | - | - | - | - | 1件: 85 85 💬
|
64 | C21 | - | - | - | - | 2件: 51 51, 85 💬
|
65 | CAL101 | - | - | - | - | 1件: 85 85 💬
|
66 | Carboplatin | 1件: Carboplatin Carboplatin | 1件: Carboplatin
Carboplatin
💬
| - | - | 4件: 28 28, 34, 60, 85 💬
|
67 | Cbdca | 1件: Carboplatin Carboplatin | 1件: Carboplatin
Carboplatin
💬
| - | - | 1件: 85 85 💬
|
68 | CC-90001 | 1件: CC-90001 CC-90001 | - | - | - | 1件: 85 85 💬
|
69 | CC-930 | - | - | - | - | 1件: 85 85 💬
|
70 | CD3/CD19 negative hematopoietic stem cells | - | - | - | - | 1件: 85 85 💬
|
71 | Centricyte 1000 | - | - | - | - | 2件: 85 85, 229 💬
|
72 | CHF10067 high dose | - | - | - | - | 1件: 85 85 💬
|
73 | CHF10067 intermediate dose | - | - | - | - | 1件: 85 85 💬
|
74 | CHF10067 starting dose | - | - | - | - | 1件: 85 85 💬
|
75 | CMR316 | - | - | - | - | 1件: 85 85 💬
|
76 | Cnto 888 1 MG/KG | - | - | - | - | 1件: 85 85 💬
|
77 | Cnto 888 15 MG/KG | - | - | - | - | 1件: 85 85 💬
|
78 | Cnto 888 5 MG/KG | - | - | - | - | 1件: 85 85 💬
|
79 | CNTO888 | - | - | - | - | 1件: 85 85 💬
|
80 | CO-trimoxazole | - | - | - | - | 1件: 85 85 💬
|
81 | Combined plasma exchange (PEX), rituximab, and corticosteroids | - | - | - | - | 1件: 85 85 💬
|
82 | Compound 21 | 1件: Buloxibutid Buloxibutid | 2件: Buloxibutid
Buloxibutid
,
Buloxibutid sodium
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
83 | Computer-assisted telephone interview | - | - | - | - | 1件: 85 85 💬
|
84 | Cotrimoxazole | - | - | - | - | 2件: 85 85, 97 💬
|
85 | Cough monitor | - | - | - | - | 1件: 85 85 💬
|
86 | Cromoglicato disodico | - | - | - | - | 1件: 85 85 💬
|
87 | Cromoglycate | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 1件: 85 85 💬
|
88 | Cromolyn | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 2件: 2 2, 85 💬
|
89 | Cromolyn sodium | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 1件: 85 85 💬
|
90 | CSL312 | - | - | - | - | 2件: 65 65, 85 💬
|
91 | CSL312 garadacimab | 1件: Garadacimab Garadacimab | 1件: Garadacimab
Garadacimab
💬
| 1件: F12 F12 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 65 65, 85 💬
|
92 | Cudetaxestat | 1件: Cudetaxestat Cudetaxestat | - | - | - | 1件: 85 85 💬
|
93 | Cyclosphamine | - | - | - | - | 1件: 85 85 💬
|
94 | Dabigatran | 1件: Dabigatran Dabigatran | 1件: Dabigatran
Dabigatran
💬
| 1件: F2 F2 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 3件: 85 85, 91, 124 💬
|
95 | Dasatinib + quercetin | 1件: Dasatinib Dasatinib | 2件: Dasatinib
Dasatinib
,
Dasatinib
💬
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| 76件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 1件: 85 85 💬
|
96 | Delivery OF 99MTC-dtpa aerosol | - | - | - | - | 1件: 85 85 💬
|
97 | Deupirfenidone | 1件: Deupirfenidone Deupirfenidone | 1件: Deupirfenidone
Deupirfenidone
💬
| - | - | 1件: 85 85 💬
|
98 | DEX284 | - | - | - | - | 1件: 85 85 💬
|
99 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 6 6, 8, 13, 21, 85, 96, 97, 156 💬
|
100 | Diet A group | - | - | - | - | 1件: 85 85 💬
|
101 | Diet B group | - | - | - | - | 1件: 85 85 💬
|
102 | Diet C group | - | - | - | - | 1件: 85 85 💬
|
103 | Digital lung sounds auscultation | - | - | - | - | 1件: 85 85 💬
|
104 | DNA sequencing | - | - | - | - | 1件: 85 85 💬
|
105 | DRY powder inhaler | - | - | - | - | 1件: 85 85 💬
|
106 | Durvalumab | 1件: Durvalumab Durvalumab | 1件: Durvalumab
Durvalumab
💬
| 1件: PDL1 PDL1 💬
| 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 💬
|
107 | DWN12088 | - | - | - | - | 1件: 85 85 💬
|
108 | Egcg | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 6件: 6 6, 8, 13, 28, 85, 206 💬
|
109 | Egcg 300 MG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 85 85 💬
|
110 | Egcg 300 MG + nintedanib | 2件: Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
111 | Egcg 300 MG + pirfenidone | 2件: Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
112 | Egcg 600 MG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 85 85 💬
|
113 | Egcg 600 MG + nintedanib | 2件: Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
114 | Egcg 600 MG + pirfenidone | 2件: Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
115 | Endobronchial infusion OF adult mesenchymal stem cells | - | - | - | - | 1件: 85 85 💬
|
116 | Endoxan | - | - | - | - | 6件: 13 13, 28, 49, 51, 85, 162 💬
|
117 | ENV-101 | - | - | - | - | 1件: 85 85 💬
|
118 | Epigallocatechin-3-gallate | 2件: Epigallocatechin Epigallocatechin, Epigallocatechin gallate | - | - | - | 3件: 8 8, 28, 85 💬
|
119 | Erivedge | 1件: Vismodegib Vismodegib | 1件: Vismodegib
Vismodegib
💬
| 1件: SMO SMO 💬
| 5件: Axon guidance Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬 | 1件: 85 85 💬
|
120 | Esbriet | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 51, 85, 228 💬
|
121 | Esbriet - 267 MG - capsula rigida - USO orale - flacone (hdpe) 270 capsule | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
122 | Esbriet 267 MG oral capsule | - | - | - | - | 1件: 85 85 💬
|
123 | Etanercept | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 15件: 15 15, 35, 38, 39, 46, 50, 53, 60, 85, 107, 228, 270, 271, 285, 298 💬
|
124 | Etoposide | 1件: Etoposide Etoposide | 2件: Etoposide
Etoposide
,
Etoposide phosphate
💬
| - | - | 12件: 11 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
|
125 | EXCL-100, 600 MG oral tablet | - | - | - | - | 1件: 85 85 💬
|
126 | EZ-2053 5MG/KG | - | - | - | - | 2件: 85 85, 299 💬
|
127 | Factor xiia antagonist monoclonal antibody | - | - | - | - | 2件: 65 65, 85 💬
|
128 | FDG PET scan | - | - | - | - | 2件: 6 6, 85 💬
|
129 | FG-3019 | - | - | - | - | 3件: 85 85, 113, 222 💬
|
130 | FG-3019 10MG/ML IN 10 ML vials | - | - | - | - | 1件: 85 85 💬
|
131 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 23件: 11 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
|
132 | Fluimucil® 600 MG effervescent tablets | - | - | - | - | 1件: 85 85 💬
|
133 | Formoterol fumarate dihydrate | 1件: Formoterol Formoterol | 2件: Formoterol fumarate
Formoterol fumarate
,
Formoterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
134 | Fostair | - | - | - | - | 1件: 85 85 💬
|
135 | Fxiia inhibitor monoclonal antibody | - | - | - | - | 2件: 65 65, 85 💬
|
136 | G-CSF | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 18件: 2 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
|
137 | G321605 | - | - | - | - | 3件: 85 85, 96, 97 💬
|
138 | G451990 | - | - | - | - | 2件: 51 51, 85 💬
|
139 | Gallium68-DOTA-NOC | - | - | - | - | 1件: 85 85 💬
|
140 | GB0139 | - | - | - | - | 1件: 85 85 💬
|
141 | GBT440 | - | - | - | - | 1件: 85 85 💬
|
142 | GBT440 300 MG capsule | - | - | - | - | 1件: 85 85 💬
|
143 | GBT440 300 MG tablet | - | - | - | - | 1件: 85 85 💬
|
144 | GC1008 | 1件: Fresolimumab Fresolimumab | 1件: Fresolimumab
Fresolimumab
💬
| 3件: TGFB1 TGFB1, TGFB2, TGFB3 💬
| 36件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 2件: 85 85, 222 💬
|
145 | Gefapixant | 1件: Gefapixant Gefapixant | 2件: Gefapixant
Gefapixant
,
Gefapixant citrate
💬
| 1件: P2RX3 P2RX3 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 2件: 85 85, 226 💬
|
146 | Genetic analysis | - | - | - | - | 7件: 34 34, 85, 90, 93, 94, 96, 234 💬
|
147 | GKT137831 | - | - | - | - | 2件: 85 85, 93 💬
|
148 | GLPG1205 | - | - | - | - | 3件: 85 85, 96, 97 💬
|
149 | GLPG1690 | - | - | - | - | 2件: 51 51, 85 💬
|
150 | GLPG1690 600 MG QD | - | - | - | - | 1件: 85 85 💬
|
151 | Granulocyte colony stimulating factor | - | - | - | - | 6件: 2 2, 28, 36, 57, 65, 85 💬
|
152 | GS-6624 | 1件: Simtuzumab Simtuzumab | - | - | - | 2件: 85 85, 94 💬
|
153 | GSK2126458 | - | - | - | - | 1件: 85 85 💬
|
154 | GSK26346763: ([18F]-FBA-A20fmdv2) IV infusion | - | - | - | - | 1件: 85 85 💬
|
155 | GSK3008348 | - | - | - | - | 1件: 85 85 💬
|
156 | GSK3008348 nebuliser solution | - | - | - | - | 1件: 85 85 💬
|
157 | GSK3915393 | - | - | - | - | 1件: 85 85 💬
|
158 | HEC 68498 | - | - | - | - | 1件: 85 85 💬
|
159 | HEC585 | 1件: Yinfenidone Yinfenidone | - | - | - | 1件: 85 85 💬
|
160 | High dose bibf 1120 twice daily | - | - | - | - | 1件: 85 85 💬
|
161 | High resolution computed tomography (hrct) scans OF THE chest | - | - | - | - | 1件: 85 85 💬
|
162 | HRS-9813 | - | - | - | - | 1件: 85 85 💬
|
163 | HSK44459 dose 1 | - | - | - | - | 1件: 85 85 💬
|
164 | HSK44459 dose 2 | - | - | - | - | 1件: 85 85 💬
|
165 | HUL001 | - | - | - | - | 1件: 85 85 💬
|
166 | Human umbilical cord mesenchymal stem cell injection | - | - | - | - | 1件: 85 85 💬
|
167 | Humanized ANTI-alpha V beta 6 MAB | - | - | - | - | 1件: 85 85 💬
|
168 | Hydroxyurea | 1件: Hydroxyurea Hydroxyurea | 1件: Hydroxyurea
Hydroxyurea
💬
| 1件: RRM2 RRM2 💬
| 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 10件: 3 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
|
169 | Hymecromone | 1件: Hymecromone Hymecromone | 1件: Hymecromone
Hymecromone
💬
| - | - | 2件: 85 85, 94 💬
|
170 | Hyperoxia | - | - | - | - | 2件: 51 51, 85 💬
|
171 | Hyperpolarized 129 xenon GAS comparing idiopathic pulmonary fibrosis (IPF) treatment | - | - | - | - | 1件: 85 85 💬
|
172 | Hyperpolarized 129 xenon GAS comparing progressive pulmonary fibrosis treatment | - | - | - | - | 1件: 85 85 💬
|
173 | Hyperpolarized 129-xenon GAS | - | - | - | - | 1件: 85 85 💬
|
174 | Hyperpolarized XE129 | - | - | - | - | 5件: 51 51, 85, 86, 88, 299 💬
|
175 | HZN-825 | - | - | - | - | 2件: 51 51, 85 💬
|
176 | IDL-2965 oral capsule | - | - | - | - | 1件: 85 85 💬
|
177 | Ifetroban sodium | 1件: Ifetroban Ifetroban | 2件: Ifetroban
Ifetroban
,
Ifetroban sodium
💬
| 1件: TBXA2R TBXA2R 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | 1件: 85 85 💬
|
178 | Iloprost | 1件: Iloprost Iloprost | 2件: Iloprost
Iloprost
,
Iloprost tromethamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 4件: 51 51, 84, 85, 86 💬
|
179 | Imatinib | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 8件: 34 34, 35, 46, 51, 85, 86, 87, 162 💬
|
180 | Immukin | - | - | - | - | 1件: 85 85 💬
|
181 | Inhaled carbon monoxide | - | - | - | - | 1件: 85 85 💬
|
182 | Inhaled nitric oxide | - | - | - | - | 2件: 85 85, 86 💬
|
183 | Inhaled nitric oxide - 30 MCG/KG IBW/HR | - | - | - | - | 1件: 85 85 💬
|
184 | Inhaled nitric oxide 5,10,15 MCG/KG IBW/HR | - | - | - | - | 1件: 85 85 💬
|
185 | Inhaled nitric oxide 75 MCG/KG IBW/HR | - | - | - | - | 2件: 85 85, 86 💬
|
186 | Inhaled TD139 | - | - | - | - | 1件: 85 85 💬
|
187 | Inhaled treprostinil | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 3件: 84 84, 85, 86 💬
|
188 | INO | - | - | - | - | 2件: 85 85, 86 💬
|
189 | Inomax 400PPM MOL/MOL inhalation GAS | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 2件: 85 85, 299 💬
|
190 | INS018_055 | 1件: INS018_055 INS018_055 | - | - | - | 1件: 85 85 💬
|
191 | Interferon alpha oral lozenge | - | - | - | - | 1件: 85 85 💬
|
192 | Interferon gamma-1B | 2件: Interferon Gamma Interferon Gamma, Interferon gamma-1b | 1件: Interferon gamma-1b
Interferon gamma-1b
💬
| 2件: IFNGR1 IFNGR1, IFNGR2 💬
| 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 💬
|
193 | Interferon-alpha lozenges | - | - | - | - | 1件: 85 85 💬
|
194 | Interferon-gamma 1B | - | - | - | - | 1件: 85 85 💬
|
195 | Intermediate dose bibf 1120 twice daily | - | - | - | - | 1件: 85 85 💬
|
196 | Intrapulmonary percussive ventilation | - | - | - | - | 1件: 85 85 💬
|
197 | IV deployment OF csvf IN sterile normal saline IV solution | - | - | - | - | 2件: 85 85, 229 💬
|
198 | IW001 | - | - | - | - | 1件: 85 85 💬
|
199 | Jaktinib hydrochloride tablets | 1件: Jaktinib Jaktinib | - | - | - | 2件: 85 85, 271 💬
|
200 | JIN-shui HUAN-xian granule | - | - | - | - | 1件: 85 85 💬
|
201 | Knottin tracer | - | - | - | - | 1件: 85 85 💬
|
202 | L - antineoplastic and immunomodulating agents | - | - | - | - | 1件: 85 85 💬
|
203 | L01 - antineoplastic agents | - | - | - | - | 1件: 85 85 💬
|
204 | L01X - other antineoplastic agents | - | - | - | - | 1件: 85 85 💬
|
205 | L01XE - protein kinase inhibitors | - | - | - | - | 1件: 85 85 💬
|
206 | L01xe31 - nintedanib | - | - | - | - | 1件: 85 85 💬
|
207 | Laboratory assessments | - | - | - | - | 1件: 85 85 💬
|
208 | Lanreotide acetate | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 4件: 67 67, 77, 85, 298 💬
|
209 | Lansoprazole | 1件: Lansoprazole Lansoprazole | 1件: Lansoprazole
Lansoprazole
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 4件: 71 71, 85, 166, 299 💬
|
210 | Lebrikizumab | 1件: Lebrikizumab Lebrikizumab | 1件: Lebrikizumab
Lebrikizumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬
|
211 | Leramistat | - | - | - | - | 1件: 85 85 💬
|
212 | Letairis | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
213 | Letairis 10 MG | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
214 | Letairis 5 MG | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
215 | Letermovir | 1件: Letermovir Letermovir | 1件: Letermovir
Letermovir
💬
| - | - | 1件: 85 85 💬
|
216 | Losartan | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
217 | LOW dose bibf 1120 twice daily | - | - | - | - | 1件: 85 85 💬
|
218 | LOW dose BIBF1120 once daily | - | - | - | - | 1件: 85 85 💬
|
219 | LPA1 | - | - | - | - | 1件: 85 85 💬
|
220 | LTI-03 | 1件: LTI-03 LTI-03 | - | - | - | 1件: 85 85 💬
|
221 | LTP001 | - | - | - | - | 2件: 85 85, 86 💬
|
222 | Lung spheroid stem cells 100 million | - | - | - | - | 1件: 85 85 💬
|
223 | Lung spheroid stem cells 200 million | - | - | - | - | 1件: 85 85 💬
|
224 | Lung stem cells | - | - | - | - | 1件: 85 85 💬
|
225 | LYT-100 | - | - | - | - | 1件: 85 85 💬
|
226 | Macitentan | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 85, 86, 88, 210 💬
|
227 | Medical AIR | 1件: Medical air Medical air | 1件: Air, medical
Air, medical
💬
| - | - | 2件: 85 85, 86 💬
|
228 | Mesna | - | - | - | - | 11件: 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
229 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
230 | Methylprednisolone hemisuccinate | 2件: Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | 4件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
,
Methylprednisolone hemisuccinate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 85 💬
|
231 | Methylprednisolone sodium hemisuccinate | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 85, 97 💬
|
232 | Methylprednisone/prednisone | 1件: Methylprednisone Methylprednisone | - | - | - | 1件: 85 85 💬
|
233 | MG-S-2525 | 1件: MG-S-2525 MG-S-2525 | - | - | - | 1件: 85 85 💬
|
234 | Minocycline | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 14件: 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
235 | Mirtazapine | 1件: Mirtazapine Mirtazapine | 1件: Mirtazapine
Mirtazapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, HTR2, HTR2, HTR2, HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 2件: 85 85, 97 💬
|
236 | Montelukast | 1件: Montelukast Montelukast | 2件: Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| 1件: CYSLTR1 CYSLTR1 💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 9件: 6 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
|
237 | Morphine hydrochloride | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
,
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 💬
|
238 | Morphine sulfate | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
,
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 85, 86 💬
|
239 | Moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
,
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 7件: 2 2, 6, 46, 49, 85, 240, 299 💬
|
240 | MTX-463 | - | - | - | - | 1件: 85 85 💬
|
241 | N-acetyl cysteine | - | - | - | - | 6件: 13 13, 34, 85, 88, 296, 310 💬
|
242 | N-acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 14件: 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
243 | NAC | - | - | - | - | 6件: 8 8, 34, 51, 85, 90, 299 💬
|
244 | NAL ER | - | - | - | - | 1件: 85 85 💬
|
245 | Nalbuphine ER 108 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
246 | Nalbuphine ER 27 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
247 | Nalbuphine ER 54 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
248 | Nalbuphine extended-realease (ER) tablets | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
249 | Nalbuphine extended-release (ER) tablets | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
250 | Nalbuphine hydrochloride | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
251 | Nandrolone decanoate | 2件: Nandrolone Nandrolone, Nandrolone decanoate | 2件: Nandrolone decanoate
Nandrolone decanoate
,
Nandrolone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 60 60, 85 💬
|
252 | ND-L02-S0201 FOR injection | - | - | - | - | 1件: 85 85 💬
|
253 | Nebivolol | 1件: Nebivolol Nebivolol | 2件: Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 113, 167 💬
|
254 | Nicotinamide riboside | 3件: Nicotinamide Nicotinamide, Nicotinamide riboside, Zinc | 1件: Niacinamide
Niacinamide
💬
| - | - | 13件: 2 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 191 💬
|
255 | Nintedanib | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 7件: 51 51, 84, 85, 89, 227, 228, 331 💬
|
256 | NIP292 tablet | - | - | - | - | 1件: 85 85 💬
|
257 | NIP292 tablets | - | - | - | - | 1件: 85 85 💬
|
258 | Nitrate-rich beetroot juice (70ML with approx. 400 MG nitrate) twice A DAY FOR 3 days | 1件: Nitrate Nitrate | 1件: Nitric acid
Nitric acid
💬
| - | - | 1件: 85 85 💬
|
259 | Nitric oxide | 1件: Nitric Oxide Nitric Oxide | 1件: Nitric oxide
Nitric oxide
💬
| - | - | 8件: 51 51, 85, 86, 88, 97, 210, 294, 299 💬
|
260 | Nivolumab | 1件: Nivolumab Nivolumab | 1件: Nivolumab
Nivolumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
261 | None YET | - | - | - | - | 3件: 51 51, 85, 222 💬
|
262 | Octreotide | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 8件: 67 67, 75, 77, 84, 85, 89, 193, 227 💬
|
263 | Ofev | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 5件: 51 51, 85, 89, 227, 228 💬
|
264 | Ofev 100 MG capsule | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
265 | Ofev 150 MG capsule | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
266 | Omeprazole | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 12件: 6 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
|
267 | ORIN1001 | - | - | - | - | 1件: 85 85 💬
|
268 | Orvepitant | 1件: Orvepitant Orvepitant | 1件: Orvepitant
Orvepitant
💬
| 1件: TACR1 TACR1 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 💬
|
269 | Orvepitant maleate | 1件: Orvepitant Orvepitant | 1件: Orvepitant
Orvepitant
💬
| 1件: TACR1 TACR1 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 💬
|
270 | Oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 13件: 22 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
|
271 | PA101 | - | - | - | - | 1件: 85 85 💬
|
272 | Paclitaxel | 1件: Paclitaxel Paclitaxel | 1件: Paclitaxel
Paclitaxel
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 85 85 💬
|
273 | Pamrevlumab | 1件: Pamrevlumab Pamrevlumab | 1件: Pamrevlumab
Pamrevlumab
💬
| 1件: CTGF CTGF 💬
| 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 2件: 85 85, 113 💬
|
274 | Paroxetine | 1件: Paroxetine Paroxetine | 4件: Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 💬
|
275 | PBI4050 | - | - | - | - | 2件: 85 85, 299 💬
|
276 | PD00377 NA-salt | - | - | - | - | 1件: 85 85 💬
|
277 | PET imaging | - | - | - | - | 1件: 85 85 💬
|
278 | PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 | - | - | - | - | 1件: 85 85 💬
|
279 | PIPE-791 | - | - | - | - | 2件: 13 13, 85 💬
|
280 | PIR, S-7701 | - | - | - | - | 1件: 85 85 💬
|
281 | Pirfenidone | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
282 | Pirfenidone and nintedanib | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
283 | Pirfenidone modified-release tablets | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
284 | Pirfenidone or nintedanib | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
285 | Pirfenidone solution FOR inhalation | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
286 | Pirfenidone tablets | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
287 | Pirfenidone, deuterated | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
288 | Pirfenidoneone | - | - | - | - | 1件: 85 85 💬
|
289 | PLN-74809 | 1件: PLN-74809 PLN-74809 | - | - | - | 2件: 85 85, 94 💬
|
290 | PLN-74809-000 | 1件: PLN-74809 PLN-74809 | - | - | - | 1件: 85 85 💬
|
291 | PLN-74809-020 | 1件: PLN-74809 PLN-74809 | - | - | - | 1件: 85 85 💬
|
292 | PMG1015 | - | - | - | - | 1件: 85 85 💬
|
293 | PMG1015 dose 1 | - | - | - | - | 1件: 85 85 💬
|
294 | PMG1015 dose 2 | - | - | - | - | 1件: 85 85 💬
|
295 | PMG1015 dose 3 | - | - | - | - | 1件: 85 85 💬
|
296 | PMG1015 dose 4 | - | - | - | - | 1件: 85 85 💬
|
297 | PMG1015 dose 5 | - | - | - | - | 1件: 85 85 💬
|
298 | PMG1015 dose 6 | - | - | - | - | 1件: 85 85 💬
|
299 | PMG1015 dose 7 | - | - | - | - | 1件: 85 85 💬
|
300 | Pomalidomide (CC-4047 | 1件: Pomalidomide Pomalidomide | 1件: Pomalidomide
Pomalidomide
💬
| 2件: IL6 IL6, TNF 💬
| 78件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
301 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
302 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
303 | Prednisonum micronisatum | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 💬
|
304 | Privigen 100MG/ML | - | - | - | - | 1件: 85 85 💬
|
305 | PRM-151 | - | - | - | - | 1件: 85 85 💬
|
306 | Pulmonary rehabilitation program | - | - | - | - | 1件: 85 85 💬
|
307 | QAX576 | - | - | - | - | 4件: 51 51, 85, 96, 98 💬
|
308 | Recombinant human pentraxin-2 | 1件: Zinpentraxin alfa Zinpentraxin alfa | 1件: Zinpentraxin alfa
Zinpentraxin alfa
💬
| - | - | 1件: 85 85 💬
|
309 | Regend001 | - | - | - | - | 1件: 85 85 💬
|
310 | Remicade | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 49, 56, 84, 85, 96, 97, 271 💬
|
311 | Revatio 20 MG | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
312 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
313 | Rixathon 500 MG | - | - | - | - | 1件: 85 85 💬
|
314 | RO 47-0203 | - | - | - | - | 4件: 51 51, 85, 86, 88 💬
|
315 | RO0220912 | - | - | - | - | 1件: 85 85 💬
|
316 | RO0280296 | - | - | - | - | 1件: 85 85 💬
|
317 | RO5490255/F01-02 | - | - | - | - | 1件: 85 85 💬
|
318 | RO7490677 | - | - | - | - | 1件: 85 85 💬
|
319 | RO7490677 160 MG/8 ML | - | - | - | - | 1件: 85 85 💬
|
320 | RO7490677 160 MG/8ML | - | - | - | - | 1件: 85 85 💬
|
321 | RO7490677 160MG/8ML | - | - | - | - | 1件: 85 85 💬
|
322 | RO7490677/ F01-02 | - | - | - | - | 1件: 85 85 💬
|
323 | RO7490677/F01-01 | - | - | - | - | 1件: 85 85 💬
|
324 | RO7490677/F01-02 | - | - | - | - | 1件: 85 85 💬
|
325 | RO7490677/F01-03 | - | - | - | - | 1件: 85 85 💬
|
326 | Routine steroid administration group | - | - | - | - | 1件: 85 85 💬
|
327 | RSN0402 part 1 | - | - | - | - | 1件: 85 85 💬
|
328 | RSN0402 part 2 | - | - | - | - | 1件: 85 85 💬
|
329 | RVT-1601 | - | - | - | - | 1件: 85 85 💬
|
330 | RXC007 | - | - | - | - | 1件: 85 85 💬
|
331 | RXC007 20 MG capsule | - | - | - | - | 1件: 85 85 💬
|
332 | RXC007 50 MG capsule | - | - | - | - | 1件: 85 85 💬
|
333 | Salbutamol | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 2 2, 3, 85, 86, 228, 256, 273, 299, 340 💬
|
334 | SAR100842 | - | - | - | - | 2件: 51 51, 85 💬
|
335 | SAR156597 | - | - | - | - | 2件: 51 51, 85 💬
|
336 | Saracatinab | - | - | - | - | 1件: 85 85 💬
|
337 | SB17170 | - | - | - | - | 1件: 85 85 💬
|
338 | SC1011 | - | - | - | - | 1件: 85 85 💬
|
339 | Senicapoc | 1件: Senicapoc Senicapoc | 1件: Senicapoc
Senicapoc
💬
| 1件: KCNN4 KCNN4 💬
| 4件: GnRH secretion GnRH secretion, Insulin secretion, Protein digestion and absorption, Salivary secretion 💬 | 1件: 85 85 💬
|
340 | Septrin | - | - | - | - | 1件: 85 85 💬
|
341 | SHR-1906 | - | - | - | - | 1件: 85 85 💬
|
342 | Sildenafil | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
343 | Sildenafil and losartan | 2件: Losartan Losartan, Sildenafil | 4件: Losartan potassium
Losartan potassium
,
Sildenafil citrate
,
Losartan
,
Sildenafil
💬
| 2件: AGTR1 AGTR1, PDE5 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
344 | Sildenafil citrate | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 4件: 51 51, 85, 86, 225 💬
|
345 | Simtuzumab | 1件: Simtuzumab Simtuzumab | - | - | - | 2件: 85 85, 94 💬
|
346 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 39件: 6 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
347 | Sivelestat | 1件: Sivelestat Sivelestat | 1件: Sivelestat
Sivelestat
💬
| 1件: ELANE ELANE 💬
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | 3件: 13 13, 85, 96 💬
|
348 | SM04646 | - | - | - | - | 1件: 85 85 💬
|
349 | Sodium cromoglicate | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 1件: 85 85 💬
|
350 | SRN-001 | - | - | - | - | 1件: 85 85 💬
|
351 | Sterile normal saline FOR intravenous USE | - | - | - | - | 2件: 85 85, 229 💬
|
352 | Steroid pulse therapy group | - | - | - | - | 1件: 85 85 💬
|
353 | SUB-study: nintedanib | - | - | - | - | 1件: 85 85 💬
|
354 | SUB-study: pirfenidone | - | - | - | - | 1件: 85 85 💬
|
355 | SUB03255MIG | - | - | - | - | 1件: 85 85 💬
|
356 | SUB10020MIG | - | - | - | - | 1件: 85 85 💬
|
357 | Sulfamethoxazole | 1件: Sulfamethoxazole Sulfamethoxazole | 1件: Sulfamethoxazole
Sulfamethoxazole
💬
| - | - | 2件: 85 85, 299 💬
|
358 | Sulphamethoxazole | 1件: Sulfamethoxazole Sulfamethoxazole | 1件: Sulfamethoxazole
Sulfamethoxazole
💬
| - | - | 1件: 85 85 💬
|
359 | Suplatast | 1件: Suplatast Suplatast | 1件: Suplatast tosilate
Suplatast tosilate
💬
| - | - | 1件: 85 85 💬
|
360 | SV001 | - | - | - | - | 1件: 85 85 💬
|
361 | Symbicort | - | - | - | - | 2件: 85 85, 228 💬
|
362 | Taladegib | 1件: Taladegib Taladegib | 1件: Taladegib
Taladegib
💬
| 1件: SMO SMO 💬
| 5件: Axon guidance Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬 | 1件: 85 85 💬
|
363 | Tazarotene | 1件: Tazarotene Tazarotene | 1件: Tazarotene
Tazarotene
💬
| 3件: RARA RARA, RARB, RXRB 💬
| 15件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Lipid and atherosclerosis, Non-small cell lung cancer, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 85 85 💬
|
364 | TBC | - | - | - | - | 4件: 85 85, 94, 96, 127 💬
|
365 | TD-1058 | - | - | - | - | 1件: 85 85 💬
|
366 | TD139 | - | - | - | - | 1件: 85 85 💬
|
367 | TDI01 suspension | 1件: TDI-01 TDI-01 | - | - | - | 1件: 85 85 💬
|
368 | Tetrathiomolybdate | 1件: Tetrathiomolybdate Tetrathiomolybdate | - | - | - | 3件: 85 85, 93, 171 💬
|
369 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
|
370 | Thalidomide pharmion | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 85 85, 96, 97 💬
|
371 | THE standard steroid treatment, plasma exchange and rituximab | - | - | - | - | 1件: 85 85 💬
|
372 | Thiotepa | 1件: Thiotepa Thiotepa | 1件: Thiotepa
Thiotepa
💬
| - | - | 11件: 13 13, 28, 46, 51, 60, 65, 85, 96, 107, 284, 285 💬
|
373 | Thrombomodulin alfa | 1件: Thrombomodulin Alfa Thrombomodulin Alfa | 1件: Thrombomodulin alfa
Thrombomodulin alfa
💬
| 1件: F2 F2 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 1件: 85 85 💬
|
374 | Tiotropium | 1件: Tiotropium Tiotropium | 1件: Tiotropium bromide hydrate
Tiotropium bromide hydrate
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 55 55, 85 💬
|
375 | Tipelukast | 1件: Tipelukast Tipelukast | 1件: Tipelukast
Tipelukast
💬
| 1件: CYSLTR1 CYSLTR1 💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 💬
|
376 | TNX-650, rhumab ANTI-IL13, AIL-13, MILR1444A | - | - | - | - | 1件: 85 85 💬
|
377 | TR0311 | - | - | - | - | 1件: 85 85 💬
|
378 | Tracleer | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,
Bosentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 13 13, 51, 84, 85, 86, 88, 210, 211 💬
|
379 | Tralokinumab | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 2件: 85 85, 97 💬
|
380 | Tralokinumab cohort 1 | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬
|
381 | Tralokinumab cohort 2 | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 💬
|
382 | Treprostinil | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 3件: 85 85, 86, 210 💬
|
383 | Treprostinil sodium FOR inhalation | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 85 85 💬
|
384 | Treprostinil ultrasonic nebulizer | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 85 85 💬
|
385 | Trimethoprim | 1件: Trimethoprim Trimethoprim | 3件: Trimethoprim
Trimethoprim
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | 3件: 36 36, 85, 299 💬
|
386 | TRK-250 | 1件: TRK-250 TRK-250 | - | - | - | 1件: 85 85 💬
|
387 | TTI-101 | 1件: TTI-101 TTI-101 | - | - | - | 1件: 85 85 💬
|
388 | Tyvaso® (treprostinil) inhalation solution, FOR oral inhalation USE | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 85 85 💬
|
389 | Untreated cohort | - | - | - | - | 1件: 85 85 💬
|
390 | Uromitexan | - | - | - | - | 1件: 85 85 💬
|
391 | Valganciclovir | 1件: Valganciclovir Valganciclovir | 2件: Valganciclovir
Valganciclovir
,
Valganciclovir hydrochloride
💬
| - | - | 6件: 28 28, 60, 85, 97, 299, 331 💬
|
392 | VAY736 | - | - | - | - | 9件: 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
|
393 | Venetoclax | 1件: Venetoclax Venetoclax | 1件: Venetoclax
Venetoclax
💬
| 1件: BCL2 BCL2 💬
| 40件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | 2件: 28 28, 85 💬
|
394 | Vismodegib | 1件: Vismodegib Vismodegib | 1件: Vismodegib
Vismodegib
💬
| 1件: SMO SMO 💬
| 5件: Axon guidance Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬 | 1件: 85 85 💬
|
395 | Vixarelimab | 1件: Vixarelimab Vixarelimab | 1件: Vixarelimab
Vixarelimab
💬
| 1件: OSMR OSMR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, PI3K-Akt signaling pathway 💬 | 3件: 51 51, 85, 97 💬
|
396 | Volibris | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 51 51, 85, 86, 88 💬
|
397 | VRP700 | - | - | - | - | 1件: 85 85 💬
|
398 | VUM02 injection | - | - | - | - | 1件: 85 85 💬
|
399 | Warfarin | 1件: Warfarin Warfarin | 3件: Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 10件: 6 6, 8, 19, 46, 49, 66, 85, 86, 88, 91 💬
|
400 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
401 | Zileuton | 1件: Zileuton Zileuton | 1件: Zileuton
Zileuton
💬
| 1件: ALOX5 ALOX5 💬
| 6件: Arachidonic acid metabolism Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬 | 3件: 85 85, 160, 164 💬
|
402 | Zinc | 1件: Zinc Zinc | - | - | - | 2件: 85 85, 171 💬
|
403 | Zinpentraxin alfa | 1件: Zinpentraxin alfa Zinpentraxin alfa | 1件: Zinpentraxin alfa
Zinpentraxin alfa
💬
| - | - | 1件: 85 85 💬
|
404 | Zinpetraxin alfa | - | - | - | - | 1件: 85 85 💬
|
405 | Ziritaxestat | 1件: Ziritaxestat Ziritaxestat | 1件: Ziritaxestat
Ziritaxestat
💬
| 1件: ENPP2 ENPP2 💬
| 1件: Ether lipid metabolism Ether lipid metabolism 💬 | 2件: 51 51, 85 💬
|
406 | ZL-2102 | - | - | - | - | 1件: 85 85 💬
|
407 | ZSP1603 | - | - | - | - | 1件: 85 85 💬
|
408 | ZSP1603 12.5 MG | - | - | - | - | 1件: 85 85 💬
|
409 | ZSP1603 25 MG | - | - | - | - | 1件: 85 85 💬
|
410 | ZSP1603 50 MG | - | - | - | - | 1件: 85 85 💬
|
411 | ZSP1603 7.5 MG | - | - | - | - | 1件: 85 85 💬
|